In response to a significant ongoing disruption to the supply of Creon® 25000 gastro-resistant capsules , a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 24th May 2024, SSP061 provides that where supplies are available, but the prescription is for more than one month’s supply the
Read moreIn response to a significant ongoing disruption to the supply of Creon® 10000 gastro-resistant capsules, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 24th May 2024, SSP060 provides that where supplies are available, but the prescription is for more than one month’s supply the total
Read moreNational Patient Safety Alert: Shortage of Pancreatic enzyme replacement therapy (PERT) National Patient Safety Alert Reference Number: NatPSA/2024/007/DHSC Date issued: 24 May 2024 This alert supersedes the Medicine Supply Notification (MSN/2024/054) issued on the 9th May 2024. This alert is for action by: All organisations involved in prescribing and dispensing pancreatic enzyme replacement therapy (PERT).
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions MSN/2024/060 Tier 2 – medium impact Date of issue: 23rd May 2024 Shortages have been reported for clarithromycin 125mg/5ml and 250mg/5ml oral suspensions. Additional stock of clarithromycin 250mg/5ml is expected to be available in wholesalers
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials MSN/2024/059 Tier 2 – medium impact Date of issue: 23rd May 2024 There will be intermittent supplies of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebules for the foreseeable future. Unlicensed supplies of salbutamol 2.5mg
Read moreThe Department of Health and Social Care (DHSC) has today (24/05/2024) confirmed the following initial list of price concessions for May 2024. This announcement comes late in the month and follows the decision by DHSC, under the direction of Ministers, to impose changes to concessions pricing from April 2024 to try to manage purchase margins. DHSC
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Nortriptyline 10mg/5ml and 25mg/5ml oral solution sugar-free MSN/2024/061 Tier 2 – medium impact Date of issue: 23rd May 2024 Nortriptyline 10mg/5ml oral solution sugar-free has been discontinued; all supplies have now been exhausted Nortriptyline 25mg/5ml oral solution sugar-free will be discontinued
Read moreClass 4 Medicines Defect Information: Sodium Chloride 0.9% Intravenous Infusion BP Freeflex and Freeflex PLUS (Fresenius Kabi Limited) Drug alert number: EL (24)A/17 Date issued: 22 May 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Sodium Chloride 0.9% Intravenous Infusion BP Freeflex and Freeflex PLUS
Read moreIn response to a significant ongoing disruption to the supply of Clarithromycin 125mg/5ml and 250mg/5ml oral suspension, Ministers have authorised the Department of Health and Social Care (DHSC) to reactivate two Serious Shortage Protocols (SSPs). Effective 22 May 2024, SSP053 and SSP054 provides for the following: SSP053 – for every 5ml of Clarithromycin 125mg/5ml oral suspension,
Read moreCommunity Pharmacy England today briefed Peers on the severe challenges facing community pharmacies, including the findings of the 2024 Pressures Survey. In a wide-ranging discussion, Peers were taken through findings on medicine supply issues, funding pressures, and pharmacy workforce shortages, as well as hearing about Pharmacy First. Chaired by former Pharmacy Minister Lord Hunt of
Read more
